Controversial firm RNL Bio quick to welcome Korean stem cell bill
This article was originally published in Scrip
Executive Summary
Political moves in South Korea to revise rules governing the use of autologous adult stem cells have found one high profile, if controversial, proponent in Dr Ra Jeong-Chan of the domestic stem cell venture RNL Bio.